Status:
TERMINATED
Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hepatitis, Viral, Human
Eligibility:
All Genders
18+ years
Brief Summary
A new approach to the evaluation of liver fibrosis has been proposed using PULSOMETRY. The objective is to evaluate the diagnostic performances of the FIBROSCAN technique, together with non-invasive t...
Detailed Description
The gold standard for the evaluation of fibrosis is considered as the METAVIR score by the clinicians. The results of this score are currently used for clinical decisions and description of the evolut...
Eligibility Criteria
Inclusion
- Chronic hepatitis B or C
- With liver biopsy indication
- Patient information
Exclusion
- Drug hepatitis
- Metabolic hepatology
- Steatosis or non-alcoholic steatohepatitis
- Autoimmune hepatopathy
- Non-contraindication to liver biopsy
- Non-contraindication to FIBROSCAN examination
- Ascites
- Obesity
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00318682
Start Date
May 1 2006
End Date
August 1 2008
Last Update
February 12 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Beaujon
Clichy, France, 92110
2
Hopital Saint-Antoine
Paris, France, 75012